543 Results

People

  1. Schoder
    Schoder
  2. Humm
    Humm
  3. Zelenetz
    Zelenetz
  4. Lee
    Lee
  5. Moskowitz
    Moskowitz
  6. Noy
    Noy
  7. Larson
    Larson
  8. Palomba
    Palomba
  9. Yahalom
    Yahalom
  10. Horwitz
    Horwitz

Groups

  1. Molecular Imaging and Therapy Service (543)
  2. Radiology, Department of (543)
  3. Department of Medicine (266)
  4. GSK Faculty (161)
  5. Hematologic Malignancies, Division of (153)
  6. Sloan Kettering Institute Postdocs (153)
  7. Survivorship Research (147)
  8. Center for Hematologic Malignancies (146)
  9. Epidemiology and Biostatistics (144)
  10. Medical Physics (144)
  1. "Heiko Schoder"
Formats
  1. Journal Article (263)
  2. Meeting Abstract (199)
  3. Book Section (31)
  4. Review (18)
  5. Editorial (14)
  6. Guidelines (8)
  7. Research Letter (6)
  8. Miscellaneous (3)
  9. Conference Paper (1)
Groups
  1. Molecular Imaging and Therapy Service (543)
  2. Radiology, Department of (543)
  3. Department of Medicine (266)
  4. GSK Faculty (161)
  5. Hematologic Malignancies, Division of (153)
  6. Sloan Kettering Institute Postdocs (153)

More Groups

People
  1. Heiko Schoder (543)
  2. John Humm (96)
  3. Steven Larson (93)
  4. Andrew Zelenetz (66)
  5. Nancy Lee (65)
  6. Alison Moskowitz (59)

More People

Years
  1. 2025 (11)
  2. 2024 (36)
  3. 2023 (42)
  4. 2022 (40)
  5. 2021 (51)
  6. 2020 (30)

More Years

Publications
  1. Journal of Nuclear Medicine (94)
  2. Journal of Clinical Oncology (60)
  3. Blood (59)
  4. International Journal of Radiation Oncology, Biology, Physics (41)
  5. European Journal of Nuclear Medicine and Molecular Imaging (38)
  6. Hematological Oncology (13)

More Publications

Publishers
  1. Society of Nuclear Medicine (94)
  2. Springer (78)
  3. Elsevier Inc. (67)
  4. American Society of Hematology (65)
  5. American Society of Clinical Oncology (60)
  6. Lippincott Williams & Wilkins (22)

More Publishers

Results (543)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective comparison of F-18-TFB and I-124 PET/CT in metastatic thyroid cancer
    Meeting Abstract

    Backhaus, P.; Pentlow, K.; Ho, A.; Mauguen, A.; Fagin, J.; Pillarsetty, N. V. K.; Lyashchenko, S.; Abusamra, M.; Larson, S.; Schoder, H.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J. R.; Devlin, S. M.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Wills, B.; Tomas, A. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Devlin, S. M.; Valtis, Y. K.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E.; Liotta, K.; Yu, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT imaging biomarkers for car-T cell therapy outcomes in large-B-cell lymphoma
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M.; Luttwak, E.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab
    Research Letter

    Stuver, R.; Vardhana, S. A.; Bedmutha, A.; Chan, K. K.; Mirtcheva-Trocheva, R.; Nosov, A.; Schòˆder, H.; Moskowitz, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Combined patient specific tumor and HPV sequencing enables high sensitivity detection of ctDNA in HPV-associated oropharyngeal carcinoma patients
    Meeting Abstract

    Diplas, B. H.; Brown, D.; Pei, X.; Graybill, C.; Novaj, A.; Korn, W. M.; Daber, R.; Humm, J.; Shukla-Dave, A.; Schoder, H.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Prospective comparison of F-18-TFB and I-124 PET/CT in metastatic thyroid cancer
    Meeting Abstract

    Backhaus, P.; Pentlow, K.; Ho, A. L.; Mauguen, A.; Fagin, J. A.; Pillarsetty, N. V. K.; Lyashchenko, S. K.; Burnazi, E.; Ghossein, R. A.; Chhabra, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT features as potent imaging biomarkers of efficacy and toxicity in large-B-cell lymphoma treated with CAR-T cell therapy
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Mauguen, A.; Devlin, S. M.; Fei, T.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; Lafontaine, D.; Michaud, L.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Development of a semi-automatic platform for whole body tumor segmentation and radiomic feature extraction from 68Ga-DOTATATE PET/CT using TriDFusion (3DF)
    Meeting Abstract

    Krebs, S.; Lafontaine, D.; Bodei, L.; Mayerhoefer, M. E.; Humm, J.; Schòˆder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save